Fas/FasL pathway-mediated alveolar macrophage apoptosis involved in human silicosis

San-qiao Yao1, Liying Wang Rojanasakul, Zhi-yuan Chen

  • 1Division of Pneumoconiosis, School of Public Health, China Medical University, Heping District, Shenyang, China. sanqiaoyao@qq.com

Insights

Alveolar macrophage apoptosis is elevated in silicosis patients, correlating with silica exposure and Fas pathway activation. This finding suggests macrophage apoptosis may serve as a biomarker for human silicosis.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Toxicology

Background:

  • Lung cell apoptosis is linked to lung fibrosis.
  • The role of alveolar macrophage (AM) apoptosis in human silicosis remains unclear.

Purpose of the Study:

  • To investigate AM apoptosis in human silicosis.
  • To explore the relationship between AM apoptosis, silica exposure, and the Fas/caspase pathway.

Main Methods:

  • Quantified apoptosis index (AI) in lung lavage fluid from silicosis patients, observers, and healthy volunteers.
  • Analyzed correlations between AI, silica exposure, soluble Fas (sFas), membrane-bound Fas (mFas), caspase-3, and caspase-8.

Main Results:

  • Silicosis patients showed significantly higher AI, mFas, and caspase-3 levels compared to controls.
  • sFas levels were decreased in silicosis patients.
  • AI correlated with silica exposure, mFas upregulation, and caspase activation, and was influenced by smoking status.

Conclusions:

  • AM apoptosis is a potential biomarker for human silicosis.
  • The Fas/FasL pathway likely regulates AM apoptosis in silicosis.
  • Findings contribute to understanding silicosis mechanisms and potential therapeutic strategies.